**THE BRITISH SOCIETY FOR CELL BIOLOGY FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Registered Charity number: 265816** 

**Jacob Cavenagh & Skeet 5 Robin Hood Lane Sutton Surrey SM1 2SW** 



## **THE BRITISH SOCIETY FOR CELL BIOLOGY** 

## **FINANCIAL STATEMENTS FOR THE** 

**YEAR ENDED 31 DECEMBER 2021** 

## **Contents** 

|||
|---|---|
|**Contents**|**Page**|
|Ofcers and Advisers|1|
|Executive Committee’s Report|2-7|
|Independent Examiner’s Report|8|
|Statement of Financial Activities|9|
|Balance Sheet|10|
|Notes to the Financial Statements|11-14|





P a g e | **1** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY Reference of Administrative Details** 

Trustees/Officers: Anne Ridley (President) Giampietro Schiavo (Treasurer appointed 03.04.2022) David Elliott (Treasurer resigned 03.04.2022) Carine De Marcos Lousa (Secretary) Jason King (Membership secretary) Anne Straube (Meetings secretary resigned 01.11.21) Susana Godinho  (Meetings  secretary appointed 01.11.21) Sharon Tooze (Honor Fell secretary) Folma Buss (Honor Fell secretary) Ann Wheeler (Newsletter secretary) Stephen Robinson Other Executive Committee Members: Maria Balda (Summer studentships) Alex Fellows                                 Victoria Cowling Viji Draviam                                  Jenny Rohn Darius Koester                              Ciaran Morrison Tom Nightingale                           Rowan Taylor Co-opted Committee Members: David Archer (Schools Liaison) Key Management Personnel: Prof A Ridley ( **President** ) Prof G Schiavo ( **Treasurer** ) Carine De Marcos Lousa ( **Secretary** ) Bankers: HSBC Bank plc Arlington Business Centre Millshaw Park Lane Leeds LS11 0PA National Savings Glasgow G58 1SB Virgin Money, Jubilee House, Gosforth Newcastle NE3 4PL Nationwide, 117 High Street Gosforth Newcastle NE3 1HA Independent Examiner: Miriam Hickson CTA FCA 5 Robin Hood Lane Sutton Surrey SM1 2SW Contact Address: c/o Prof G Schiavo Queen Square Institute of Neurology University College London Queen Square London WC2N 3BG 



P a g e | **2** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021** 

The Officers (who are the trustees of the Society for the purposes of charity law) have pleasure in presenting their report and the independently examined accounts of the Society for the year ended 31 December 2021. These accounts have been prepared in accordance  with the Charities Act 2011, the Statement of Recommended Practice (Charities SORP 2015 (FRS102)), Financial Reporting Standard 102 (FRS 102); and the constitution of the Society. 

## **Structure, Governance and Management** 

## **Officers and committee** 

Under the constitution of the Society, the Officers of the Society are a President, a Secretary, a Treasurer, a Meetings Convenor, a Membership Secretary, a Newsletter Editor and a Website Co-ordinator. There is also an Executive Committee of the Society consisting of the Officers and twelve other elected members. 

The Executive Committee is elected at the Annual General Meeting, with the Officers being elected by the Executive Committee and the President being nominated by the Executive Committee. 

The trustees are trained by having an at least 1 year transition period in which case the new trustee shadows the previous trustee, thus ensuring they know how to fill the role. 

The  Executive  Committee  prepares  the  Agenda  for  meetings  of  the  Society,  and between meetings acts as necessary on behalf of the Society; reporting on any such actions to the next meeting of the Society. 

The individuals who served as Officers and Executive Committee members during the year, and since the year-end, were as follows: 

|Dr D Archer|(Joined1998)|Dr C de Marcos Lousa|Dr C de Marcos Lousa|(Joined|
|---|---|---|---|---|
|2018)|||||
|||Dr J King|(Joined|2018)|
|||Prof C Morrison|(Joined|2019)|
|Dr A Straube|(Joined2015)||||
|Dr V Ponnambalam|(Joined 2015)|Ms R Taylor|(Joined|2020)|
|||Prof V Cowling||(Joined|
|2020)|||||
|Prof M Balda|(Joined 2016)|Dr T Nightingale|(Joined|2020)|
|Prof D Elliott|(Joined 2016)|Prof G Schiavo||(Joined|
|2020)|||||
|Dr A Wheeler|(Joined 2016)|Dr A Fellows|(Joined|2020)|
|Dr S Godinho|(Joined 2017)|DrD Koester|(Joined|2021)|
|Dr F Buss|(Joined 2017)|Prof V Draviam||(Joined|
|2021)|||||
|Dr S Tooze|(Joined 2017)||||
|Prof A Ridley|(Joined 2017)||||
|Dr S Robinson|(Joined 2017)||||
|Dr J Rohn|(Joined 2017)||||





Page 13

P a g e | **4** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021** (CONTINUED) 

The Executive Committee members in office at the date of this report are detailed on the previous page. The Key Management Personnel of the charity as listed on page 1 are in charge of directing, controlling, running and operating the charity on a day to day basis. No remuneration is paid to any of the Key Management Personnel or the other trustees. 

## **Constitution** 

The Society is constituted under a constitution executed in 1965 and amended in 2014. The Society is a registered charity, number 265816. 

## **Risk assessment** 

The  major  risks  to  which  the  Society  is  exposed,  as  identified  by  the  Executive Committee, have been reviewed in the year and systems are in place to mitigate those. 

As we are a society, one major risk is a drop in numbers of members. To mitigate this risk, we have introduced easier ways of maintaining membership via direct debit, and introductory packages for PhD students that include 3 years membership at reduced rate. We hope that once students see the benefit of membership they will continue once they graduate. 

## **Objectives and Activities** 

The objects of the Society are to promote the advancement of research in relation to all branches of cell biology and to encourage  the interchange of information and support career development. The Society generally aims to fulfil these objects by organising  and  sponsoring  meetings  each  year  on  topics relevant  to  cell  biology; funding  travel  grants  to  PhD  students,  postdoctoral  scientists  and  group  leaders; Funding training courses in Cell Biology for early career scientists; Issuing a yearly newsletter and maintaining a website (www.bscb.org). 

The Executive Committee confirm that they have had due regard to the guidance issued by the Charity Commission relating to public benefit. 

## **Achievements and Performance** 

The Company of Biologists awarded the BSCB with a Block Grant of £35,000 in 2020, and also kindly allowed us to carry over funding for our HF Travel Grants, and grants for PI travel and Practical Courses.  The support provided by the Company of Biologists (COB) is vitally important for the BSCB and enables it to promote Cell Biology within the UK across schools, universities and to support the research community. Given the continuing  worldwide  COVID-19  pandemic,  all  in person  conferences and meetings planned for this year have been cancelled. As a result of this we have not spent much of the Travel grants. We have been supporting science in other ways for which we have used our block grant. 

**Membership:** We currently have 961  members,  of  which  352  are  students.  We recruited  122  new  members  this  year,  and  are  going  to  have  new  membership initiatives in the autumn to catch new students. Our membership fulfilment services are provided by HG3 Ltd. 

**Scientific Networking** : Normally much of the activity of the BSCB is centered around organising world-class scientific meetings for the Cell Biology community. Unfortunately, in person meetings have been affected by the pandemic. In Spring 2021 we held a joint meeting with the Biochemical Society (Dynamic Cell IV), that was held 



P a g e | **5** 

virtually. This event was successful - with 236 participants,  national and international speakers, BSCB-funded poster prizes for PhD students and postdocs (1st, 2nd, and 3rd), and special sessions, including on grant writing, that were well attended and interactive. 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021** (CONTINUED) 

**Career  development.** At  our  Dynamic  Cell  IV  Meeting  our  postdoc  and  PhD representatives (1) ran a student/postdoc symposium, choosing 10 speakers from 70 submitted abstracts; (2) a careers event; (3) an interactive discussion about social media in science; and (4) organized the pub quiz and a “meet the medal winners” event. The BSCB committee also launched a brand-new scheme for supporting regional meetings  run  by  PhD  students  and  postdocs  on  careers  and  networking.  This  is advertised now on our website. Given the current COVID-19 situation we have not had many applications, but we hope this will pick up when in-person meetings are possible again. We are encouraging these events to include more than one institution, and to be open to members from across the UK. 

**Summer Internships:** These awards are to encourage the very best undergraduate students to consider research  careers in the field of Cell Biology. Awards were based on competitive application, scored by 6 members of the BSCB committee. We received 32 applications and chose 12 for funding in 2021. These research  projects  were  asked  to  be  designed  so  that  they  could  be  carried  out remotely, if necessary, e.g., using bioinformatics approaches, with a description of how  remote  supervision  would  be  conducted.  We  also  increased  our  stipend  to £300/week (to be in line with the minimum wage for under 23s, which is £8.20 for a 36.5-hour week), and most projects are for 8 weeks. Each of the students will produce a report, some of which will be published in our annual BSCB newsletter Magazine. 

**Scientific Awards:** We continued to promote Cell Biology in the UK by awarding prestigious scientific prizes at multiple career levels. The Hooke medal is awarded to an outstanding cell biologist who started their own lab within the last 14 years. This year we awarded our **Hooke Medal** to Stephen Royle of the University of Warwick for his work on membrane trafficking and mitosis in human cells. Another senior award is the Women in Cell Biology (WICB) Early Career Medal, which was established in 2015 to mark the 50[th] anniversary of the founding of the BSCB. It is an annual honour awarded to an outstanding female cell biologist who has started her own research group in the UK within the last seven years. In 2021, the WICB award went to Vivian Li of the Francis Crick Institute in London for her work on the regulation of intestinal homeostasis  and  cancer. This  BSCB award contributes  to  recognising  women’s success and provides role models 

for  future generations.  These prize winners are displayed on our website. Both Stephen and Vivian were awarded their prizes by our president Anne Ridley, at a virtual  joint  meeting  between  the  BSCB  and  the  French  Society  for  Cell  Biology, originally planned in Cell La Vie (F), in September 2021. 

This  year  we  also  introduced  two  new  prizes.  These  prizes  were  conceived  and developed by our previous and current BSCB committee postdoc (Gautam Dey, UCL; Alex Fellows, MRC LMB) and PhD (Joyce Yu, Crick Institute; Rowan Taylor, University of Leeds) representatives. This involved the design and manufacture of 2 new medals, with bespoke designs from Beata Science Art being chosen by the BSCB committee. 



P a g e | **6** 

In the **BSCB postdoc award** we are looking for the next generation of inspirational scientific  leaders.  The  awardee  receives  free  registration,  accommodation,  and UK/Ireland travel for the next BSCB annual meeting at which they will be presented with a medal and give a short talk. **Agathe Chaigne** won our first ever Postdoc award. Agathe is a Sir Henry Wellcome postdoctoral fellow at the MRC Laboratory for Molecular Cell Biology, University College London, and discovered a key role for the last step of division, abscission, in regulating exit from naive pluripotency. 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021** (CONTINUED) 

**Flora Paldi** won our inaugural **Raff Medal** for PhD student research. Flora’s PhD project (University of Edinburgh) focused on the role of pericentromeric chromosome structure in mitotic chromosome segregation. Flora communicated her findings to national and international conferences. Her work was recently published in Nature, and  demonstrated  a  direct,  causal  relationship  between  the  three-dimensional organisation of a specific  domain with cellular function.  Flora was also an active member of the PhD scientific community, and is currently a postdoctoral researcher in Montpellier, France. Both Agatha and Flora were awarded their medals virtually this year at our Dynamic Cell meeting (March 2021), and received their medals by post. Details of their work are on our website. 

We run two additional competitions each year which are open to junior scientists: the **BSCB Science Writing Prize** and **Image  Competition** with  deadlines  in July  2021. The winning essay and images will be presented on our website and in our magazine. 

**Supporting attendance at scientific meetings** . Because attending international meetings is a crucial aspect of early career scientist training, we attempt to fund all eligible  applications.  This  year  has  been  a  bit  slower  because  of  the  worldwide pandemic. 

**Outreach Activities:** Committee member Jenny Rohn from University College London (UCL) is our “Science Advocacy and Outreach Officer”. Again, there has been less on this year because of the pandemic. Jenny has used the email list of interested BSCB members to coordinate our society’s responses to various calls for consultation issued by the Royal Society of Biology (of which we are a Member Organisation). These have included  an  all-party  parliamentary  group  investigating  diversity  and  inclusion  in science, technology, engineering and mathematics (STEM) to promote a diverse and inclusive  environment;  and  a  DEFRA  (Department  of  Environment,  Food  and  Rural Affairs) consultation on non-human genome editing and genetically modified organisms.  Key  science  policy  information  is  shared  with  our  membership  via  the website and Magazine 

We recently published our 2021 BSCB Magazine to publicize the BSCB and our work, and we maintain an active twitter feed. The BSCB magazine is in colour, and posted to all members as well as being available on our website. Tom Nightingale and Ciaran Morrison are taking over as committee members responsible for the Magazine from Ann Wheeler. 



P a g e | **7** 

We continue to support public engagement via education, through e-learning pages ‘softCELL and ‘CELLpics’ on our website. David Archer, our Schools Liaison officer, is updating sections on cancer at the moment, and these are going to be uploaded on our website.  David  also  wrote  a  piece  about  the  effect  that  Covid-19  was  having  on children’s education for our Magazine. 

**Website and Social Media:** The BSCB website allows members and the wider cell biology community to keep informed about our activities. The Company of Biologists logo is placed in a prominent position on the top of the sidebar and on every page, and the Company of Biologists’ very generous support is acknowledged on the main landing page text and at various places throughout the site. We also promote the Company of Biologists events and journals on our website and in our Magazine, and through re-tweeting. This year we have a new website officer, Stephen Robinson, who has taken over from Judith Sleeman. Stephen is working to revamp our website this year. 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021** (CONTINUED) 

## **Financial Review** 

## **Reserves** 

The Executive Committee regularly reviews the reserves of the charity to ensure that sufficient liquid funds are available for the Society to meet its ongoing obligations. The trustees require a level of unrestricted free reserves of £125,000 to meet existing and committed expenditure in case income is not received. Total funds at 31 December 2021 were £330,891 (2020 funds: £327,495, and 2019: £249,948). Of these, £78,376 (2020:  £81,485)  were  restricted  unspent  COB  grants.  Unrestricted  funds,  which constitute free reserves were  £252,515 (2020: £246,010). The current level of free reserves is therefore higher than is needed to cover all the existing and committed expenditure. 

We introduced a vacation studentship scheme in 2011 to provide training opportunities for undergraduate students. These will utilise some of the reserves in a controlled manner over several years. 

## **Investment Policy** 

The Executive Committee’s policy at present is to invest in low-risk and reasonably liquid assets, so that funds are available to meet any unforeseen needs that arise because of meeting activities. 

## **Future Plans** 

We have an exciting joint meeting planned with the French Society for Cell Biology. We will also support a number of other cell biology meetings in response to funding applications. Planning for future meetings has commenced. We will continue to support 



P a g e | **8** 

1 day focused meetings, summer studentships and more generally Cell Biology in the UK. 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021** (CONTINUED) 

## **Executive Committee’s Responsibilities** 

The  Executive  Committee  is  responsible  for  preparing  the  Annual  Report  and  the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice. 

Charity law requires the Executive Committee to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the Society and of the surplus or deficit for that period. In preparing those financial statements, the Executive Committee have: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgments and estimates that are reasonable and prudent; 

- state  whether  applicable  UK  Accounting  Standards  have  been  followed, subject  to  any  material  departures  disclosed  and  explained  in the  financial statements; and 

- prepare  the  financial  statements  on  the  going  concern  basis  unless  it  is inappropriate to presume that the charity will continue in business. 

The Executive Committee has overall responsibility for ensuring that the Society has an appropriate  system  of  controls,  financial  and  otherwise.   It is  also  responsible  for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Society.  It is also responsible for safeguarding the 



P a g e | **9** 

assets of the Society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

Giampietro Schiavo **Trustee** 

24/06/2022 



P a g e | **10** 

## INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF **THE BRITISH SOCIETY FOR CELL BIOLOGY** 

I report to the charity trustees on my examination of the accounts of the Trust (the Trust) for the year ended 31 December 2021. 

## **Responsibilities and basis of report** 

As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’). 

I report in respect of my examination of the Trust’s accounts as carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 

## **Independent examiner’s statement** 

I  have  completed  my  examination.   I  confirm  that  no  matters  have  come  to  my attention in connection with the examination giving me cause to believe that in any material respect: 

1. accounting records were  not  kept  in respect of  the  Trust  as required by section 130 of the Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Report) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS 102) 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Miriam Hickson CTA FCA Jacob Cavenagh & Skeet 5 Robin Hood Lane Sutton Surrey SM1 2SW 

Date: 



P a g e | **11** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR TO 31 DECEMBER 2021** 

|**Not**<br>**e**<br>**Unrestrict**<br>**ed Funds**<br>**Restrict**<br>**ed**<br>**Funds**|**Not**<br>**e**<br>**Unrestrict**<br>**ed Funds**<br>**Restrict**<br>**ed**<br>**Funds**|**Not**<br>**e**<br>**Unrestrict**<br>**ed Funds**<br>**Restrict**<br>**ed**<br>**Funds**|**Not**<br>**e**<br>**Unrestrict**<br>**ed Funds**<br>**Restrict**<br>**ed**<br>**Funds**|**Not**<br>**e**<br>**Unrestrict**<br>**ed Funds**<br>**Restrict**<br>**ed**<br>**Funds**|**Total**<br>**2021**<br>**Unrestrict**<br>**ed Funds**<br>**Restricted**<br>**Funds**|**Total**<br>**2021**<br>**Unrestrict**<br>**ed Funds**<br>**Restricted**<br>**Funds**|**Total**<br>**2021**<br>**Unrestrict**<br>**ed Funds**<br>**Restricted**<br>**Funds**|**Total**<br>**2021**<br>**Unrestrict**<br>**ed Funds**<br>**Restricted**<br>**Funds**|**Total**<br>**2021**<br>**Unrestrict**<br>**ed Funds**<br>**Restricted**<br>**Funds**|**Total**<br>**2021**<br>**Unrestrict**<br>**ed Funds**<br>**Restricted**<br>**Funds**||**Total**<br>**2020**|**Total**<br>**2020**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|**Income from:**||**£**||**£**|**£**|||**£**||**£**||**£**||
|Grants<br>2||35,000||-|35,000|||35,000||62,500||97,500||
|Investments||36||-|36|||887||-||887||
|||||||||||||||
|**_Charitable_**<br>**_activities_**||||||||||||||
|Subscriptions||26,353||-|26,353|||30,057||-||30,057||
|Other income||-||-|-|||3,547||-||3,547||
|**Total income**||61,389||-|61,389|||69,491||62,500||131,99<br>1||
|||||||||||||||
|||||||||||||||
|**Expenditure on:**||||||||||||||
|||||||||||||||
|**_Charitable_**<br>**_activities_**||||||||||||||
|Grants payable:||||||||||||||
|CoB<br>4||-||3,109|3,109|||-||4,650||4,650||
|Other grants||148||-|148|||1,030||500||1,530||
|||||||||||||||
|Studentships||29,719||-|29,719|||20,865||-||20,865||
|Costs of meetings||2,537||-|2,537|||3,374||-||3,374||
|Website expenses||728||-|728|||588||-||588||
|Newsletter costs||4,049||-|4,049|||4,075||-||4,075||
|Membership<br>fulflment services||11,609||-|11,609|||13,724||-||13,724||
|<br>Examiner’s<br>remuneration||2,950||-||2,950||2,760||-|||2,760|
|Miscellaneous||163||-||163||219||-|||219|
|Subscriptions||1,558||-||1,558||1,542||-|||1,542|
|Insurance<br>||1,423<br>||-||1,42<br>3<br>||1,117<br>||-|||1,11<br>7|
|||||||||||||||
|**Total expenditure**||54,884||3,109|57,993|||49,294||5,150||54,444||
|||||||||||||||
|||||||||||||||
|**Net**<br>**(expenditure)/inco**<br>**me**||6,505||(3,109)|3,396|||20,197||57,350||77,547||
|||||||||||||||
|Transfer between<br>funds||-||-|-|||-||-||-||
|||||||||||||||
|||||||||||||||
|**Net movement in**<br>**funds**||6,505||(3,109)|3,396|||20,197||57,350||77,547||
|||||||||||||||
|Funds brought<br>forward at 1 January<br>2021|246,010|||81,485|327,495||225,813|||24,135|249,948|||





P a g e | **12** 

**Funds carried forward at 31 December 2021** 


252,515 

78,376 330,891 246,010 81,485 327,495 



P a g e | **13** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY BALANCE SHEET AS AT 31 DECEMBER 2021** 

|**Current assets:**<br>Debtors<br>5<br>Cash at bank and in hand<br>**Liabilities:**<br>_Creditors: amounts falling due in one_<br>_year_<br>6<br>**Total assets less current liabilities**<br>7<br>**Funds**<br>Restricted funds<br>4<br>Unrestricted funds<br>**Total funds**||**2021**<br> <br>**£**<br> <br>1,213<br>341,815<br>343,028<br>12,137<br>330,891<br>78,376<br>252,515<br>330,891|<br> <br>|**2020**<br>**£**<br>2,859<br>337,304|
|---|---|---|---|---|
||<br>||<br>|<br>340,163<br>12,668|
|||||<br>327,495|
|||||81,485<br>246,010|
|||||327,495|



Approved by the Trustees 24/06/2022 and signed on their behalf by: 

Carine Marcos de Lousa Giampietro Schiavo **Trustee Trustee** 



P a g e | **14** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021** 

## **1. Accounting Policies** 

The Society is constituted under a constitution executed in 1965, and amended in 2014. The Society is a registered charity, number 265816. It’s registered office is C/O Prof G Schiavo, Queen Square Institute of Neurology **,** University College London **,** Queen Square, London WC2N 3BG. The Society meets the definition of a public benefit entity under FRS 102. 

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows: 

## a) Basis of accounting 

The financial statements are prepared in accordance with the charity’s constitution, the Charities Statement of Recommended Practice (Charities SORP (FRS 102)) and Financial Reporting Standard 102  (FRS 102). The  financial statements are  drawn up on the historical cost basis of accounting. The financial statements are prepared in sterling, which is the functional currency of the charity and rounded to the nearest £. 

The trustees have prepared detailed forecasts and cashflow projections which they believe are based upon reasonable assumptions. The forecasts show that the charity should be able to operate for the foreseeable future and thus the trustees consider it appropriate to prepare the financial statements on a going concern basis. 

## b) Funds 

General unrestricted funds represent the funds of the Society that are not subject to any restrictions regarding their use and are available for application on the general purposes of the Society. 

Restricted funds are those subject to specific trusts, which may be declared by the donor or with their authority. The restricted funds of the Society are restricted income funds  given  for  specific  purposes,  which  are  expendable  at  the  discretion  of  the Executive Committee in accordance with particular activities of the Society. 

## c) Income 

Voluntary income and donations (including legacies) are accounted for once the charity has entitlement to the income, it is probable the income will be received and the amount of income receivable can be reliably measured. 

Subscriptions and mailing  list sales represent  amounts  receivable  during  the  year. Meetings  income  is  recognised  in  the  period  when  the  meeting  takes  place  and investment income (which represents interest on National Savings deposits and bank accounts) are the amounts receivable for the year. 

## d) Expenditure 

Expenditure is accrued as soon as a liability is considered probable, discounted to present value for longer term liabilities. 

Certain expenditure is directly attributable to specific activities and has been included in those cost categories. Support and governance costs attributable to more than one activity are apportioned across categories based on an estimate of the proportion of time spent by staff on those activities. 



P a g e | **15** 

Grants and awards are accounted for when paid over, or when awarded, if that award creates a binding obligation on the charity. 



P a g e | **16** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021 (continued)** 

## **1. Accounting Policies (continued)** 

## e) Joint arrangements 

Where applicable the share of income and expenditure from joint arrangements to put on  meetings  in  the  year  is  accounted  for  under  the  appropriate  heading  in  the Statement of Financial Activities. 

## f) Debtors 

Grants  receivable  and  other  debtors  are  included  at  the  settlement  amount  due. Prepayments are valued at the amount prepaid. 

## g) Cash at bank and in hand 

Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of opening of the deposit. 

## h) Creditors and provisions 

Creditors and provisions are recognised where the charity has a present obligation arising from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are recognised at their settlement amount. 

## i) Financial instruments 

The charity only has financial assets and liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value. 

## j) Foreign currency translation 

Transactions in foreign currency are translated at the rate ruling on the date of the transaction. Balances denominated in foreign currencies are retranslated at the yearend, with the gain or loss on retranslation going through the Statement of Financial Activities for the year. 

## **2. Grants received** 

Grants of £35,000 (2020: £97,500) were received from The Company of Biologists during the year. £nil (2020: £62,500) of this was restricted as set out in Note 4 below, and £35,000 (2020: £35,000) was unrestricted. 

## **3. Executive Committee members and employees** 

No Executive Committee member or any person connected with them, nor any of the Key Management Personnel received, or is due to receive, any remuneration for the year directly or indirectly from the Society's funds. 

There were Nil Executive Committee members paid in 2021 (2020: nil) in respect of reimbursed travel, subsistence and accommodation expenses during the year. There were Nil third parties paid in 2021 (2020: nil) of costs for the Executive Committee to attend  the  Annual  Spring  Meeting.  Nil  (2020:  nil)  Executive  Committee  Members received Travel Grants of Nil (2020: £nil). 

The Society has no employees. 



Page 117

P a g e | **18** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021 (continued)** 

## **4. Restricted funds** 

**2021** 

|**2021**|**2021**|||
|---|---|---|---|
|**Balance b/f**<br>**£**<br>Abercrombie Conference Fund<br>1,324<br>CoB/Honor Fell Travel Fund<br>41,096<br>CoB/PI Travel Fund<br>33,422<br>CoB/Training Course Fund<br> 5,643<br> <br>81,485||**Incom**<br>**e**<br>**Expenditur**<br>**e**<br>**Transfer**<br>**s**<br>**Balance**<br>**c/f**<br>**£**<br>**£**<br>**£**<br>**£**<br>-<br>-<br>-<br>1,324<br>-<br>3,109<br>-<br>37,987<br>-<br>-<br>-<br>33,422<br>  -<br> -<br> -<br> 5,643<br> -<br> 3,109<br> -<br>78,376||
||41,096|-<br>|37,987|
||33,422|-<br>|33,422|
||5,643<br>|-<br>|5,643|
||81,485|-<br>|78,376|



**2020** 

|**2020**|**2020**|||
|---|---|---|---|
|**Balance b/f**<br>**£**<br>Abercrombie Conference Fund<br>1,824<br>CoB/Honor Fell Travel Fund<br>8,246<br>CoB/PI Travel Fund<br>13,422<br>CoB/Training Course Fund<br>643<br>24,135||**Incom**<br>**e**<br>**Expenditur**<br>**e**<br>**Transfe**<br>**rs**<br>**Balance**<br>**c/f**<br>**£**<br>**£**<br>**£**<br>**£**<br>-<br>500<br>-<br>1,324<br>37,500<br>4,650<br>-<br>41,096<br>20,000<br>-<br>-<br>33,422<br> 5,000<br>  -<br> -<br> 5,643<br>62,500<br> 5,150<br> -<br>81,485||
||8,246|37,500<br>|41,096|
||13,422|20,000<br>|33,422|
||643|5,000<br>|5,643|
||24,135|62,500<br>|81,485|



The Abercrombie Conference Fund is money held on behalf of the Trustees of the Abercrombie Conference Fund which will be used to sponsor meetings on cell motility. 

The CoB/Honor Fell Travel Fund relates to funds granted specifically to enable the making of grants to student delegates to cover the costs of travel to meetings of the Society. 

The CoB/PI Travel Fund relates to grants made to members and principal Investigators to enable them to travel to cell biology meetings – not just BSCB meetings, but also other meetings where cell biology is covered. 

The CoB/Training Course Fund relates to grants made to members to attend training courses. 

Further details of the awards made in the year are given in the Executive Committee’s Report. 



P a g e | **19** 

## **THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021 (continued)** 

|**5.**<br>**Debtors**||||||**2020**<br>**£**<br>2,859<br>**2020**<br>**£**<br>12,668|**2020**<br>**£**<br>2,859<br>**2020**<br>**£**<br>12,668|
|---|---|---|---|---|---|---|---|
|||||**2021**||||
|||||**£**||||
|Prepayments and accrued income||||1,213||||
|||||||||
|||||||||
|**6.**<br>**Creditors due within one year**||||||||
|||||||||
|||||**2021**||||
|||||**£**||||
|Accruals and deferred income|||12,137|||||
|||||||||
|||||||||
|||||||||
|**7**<br>**.**<br>**Analysis of net assets by fund**||||||||
||**Unrestricte**<br>**d**||**Restricte**<br>**d**||||**Total**|
||**Funds**||**Funds**||||**Funds**|
||**£**||**£**||||**£**|
|Current assets|264,652||78,376||||343,028|
|Current liabilities|(12,137)||-||||(12,137<br>)|
|At 31 December 2021|252,515||78,376||||330,891|
|||||||||
||**Unrestricte**<br>**d**||**Restricte**<br>**d**||||**Total**|
||**Funds**||**Funds**||||**Funds**|
||**£**||**£**||||**£**|
|Current assets|258,678||81,485||||340,163|
|Current liabilities|(12,668)||-||||(12,668<br>)|
|At 31 December 2020|246,010||81,485||||327,495|